These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Characteristics of motor function of the duodenum in diseases of the gastrointestinal tract. (Based on duodenographic and duodenotonometric data]. Samson EI; Migovan NK Ter Arkh; 1966 Jan; 38(1):34-7. PubMed ID: 5982210 [No Abstract] [Full Text] [Related]
25. [Effect of the concomitant pathologies of the hepatobiliary system on the ulcer course and substantiation of the use of Essliver Forte as a part of the complex therapy]. Shkatova EIu; Mufazdalova IV; Khokhlacheva NA Eksp Klin Gastroenterol; 2006; (4):43-7. PubMed ID: 17269423 [No Abstract] [Full Text] [Related]
27. [Disorder in mechanisms of bile formation and methods of their correction]. Iakovenko EP; Grigor'ev PIa; Agafonova NA; Iakovenko AV; Prianishnikova AS Eksp Klin Gastroenterol; 2003; (6):32-9. PubMed ID: 15065526 [No Abstract] [Full Text] [Related]
28. Natural history of peptic ulcer disease in Poland. Part VIII. Peptic ulcer disease and diseases of the liver, bile ducts and gallbladder. Ruzyłło E; Godziemba-Maliszewska E; Tacikowski T Mater Med Pol; 1990; 22(3):225-32. PubMed ID: 2132431 [TBL] [Abstract][Full Text] [Related]
30. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system]. Nogaller AM; Barkhanova AG; Zakharova GIu Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457 [No Abstract] [Full Text] [Related]
31. [Therapeutic use of a dried protein mixture in peptic ulcer]. Kolomoets MIu Vrach Delo; 1983 Nov; (11):55-7. PubMed ID: 6659459 [No Abstract] [Full Text] [Related]
32. [The mental status characteristics of patients with peptic ulcer and chronic cholecystitis]. Volkov VS; Smirnova LA Ter Arkh; 1995; 67(2):20-2. PubMed ID: 7725251 [TBL] [Abstract][Full Text] [Related]
33. Cimetidine and platelet function in peptic ulcer patients. Bertaglia G; Miglietta A Thromb Haemost; 1993 Feb; 69(2):214. PubMed ID: 8456436 [No Abstract] [Full Text] [Related]
34. [Effect of caerulein on gastric secretion and peptic ulcer]. Radecki T; Konturek S; Biernat J; Thor P Acta Physiol Pol; 1971; 22(5):597-608. PubMed ID: 5116960 [No Abstract] [Full Text] [Related]
35. [Personal experiences in the treatment of bile duct diseases using Genebil]. De Marcos Perez VM Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):569-84. PubMed ID: 5363141 [No Abstract] [Full Text] [Related]
36. [Hemodynamic indices in patients with peptic ulcer under treatment with gangliolytics]. Ivanova EA Vrach Delo; 1971 Jun; (6):21-6. PubMed ID: 4398430 [No Abstract] [Full Text] [Related]
37. [Use of urolesan and phenicarbaran in the combined treatment of chronic cholecystitis]. Neĭko EM; Skrobach NV Vrach Delo; 1985 Jul; (7):13-6. PubMed ID: 4049815 [No Abstract] [Full Text] [Related]
38. [Upper endoscopy in the etiological diagnosis of pyloric syndrome]. Maggiolo P; Arteaga H; Pfau J; Klinger J Rev Med Chil; 1984 May; 112(5):474-8. PubMed ID: 6505438 [No Abstract] [Full Text] [Related]
39. [Treatment of gastroduodenal ulcers and peptic esophagitis with a deproteinized calf serum extract]. Debray C; Paolaggi JA; Couturier D Therapeutique; 1972 Mar; 48(3):199-206. PubMed ID: 5071021 [No Abstract] [Full Text] [Related]